1 Product identity
Ingredient risk
1 ingredient to use with caution

Double Strength Saffron

BrandWindmill Health ProductsBotanical Tablet or Pill 8 ingredients 1 caution DSLD #19017
Net contents: 60 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-03-25
2 Ingredients (8)
IngredientGroupSafety
Saffron extractSaffron
Dicalcium PhosphateCalciumConditionally Safe
Microcrystalline CelluloseCellulose
Stearic AcidStearic Acid
Croscarmellose SodiumCroscarmellose Sodium
Magnesium StearateMagnesiumUse with Caution
SilicaSiliconGenerally Safe
CoatingCoating
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Saffron Extract — Limited Evidence
⚠ Toxic at 5+ g (abortifacient, hemorrhagic)
⚠ May enhance serotonergic drugs
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Silicon — Generally Safe
⚠ Very low toxicity
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID19017
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-03-25
6 More from Windmill Health Products
View Windmill Health Products Safety Scorecard → 11 products
Chewable Vitamin D 400 IUGreen Coffee BeanNature's Aphrodisiac For WomenRaspberry SlimVITAdrops Gummies Adult Multi-VitaminsVITAdrops Gummies Children's DHA
7 Cite this page
Vancouver
Pkhakadze G. Double Strength Saffron — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 27]. Available from: https://academy.gmj.ge/products/double-strength-saffron-19017/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
© 2026 supplement.ge · PHIG · Sheni Network